Emcure Pharmaceuticals Set To Go Public? Here's What Namita Thapar Said At GBS 2024

emcure pharmaceuticals set to go public? here’s what namita thapar said at gbs 2024

Namita Thapar, CEO of Emcure Pharmaceuticals, shared her venture into startup investments during the session at the ET NOW Global Business Summit 2024. Hailing from a lineage of first-generation entrepreneurs, Thapar expressed her heartfelt motivation to contribute to the entrepreneurial ecosystem.

Her participation in Shark Tank India was driven by a passion for giving back and a belief in the significance of staying connected with the dynamic startup landscape. Thapar’s enthusiasm was not only rooted in the platform’s vitality but also in her recognition of technology as a pivotal solution for addressing crucial challenges within the pharmaceutical sector. Specifically, she emphasized the potential of technology to tackle issues related to awareness, accessibility, and affordability.

Thapar also disclosed that Emcure Pharmaceuticals is on the verge of going public, a move which is slated to unfold within the next three months.

About ET Now Global Business SummitThe Times Group presents the ET Now Global Business Summit as a distinguished platform that has in the past hosted an illustrious array of personalities, both from India and around the world.